Investment Summary

Toho Holdings Invests In Hirosaki LI

On June 24, 2024, Toho Holdings invested in life science company Hirosaki LI

Investment Highlights
  • This is Toho Holdings’ 1st transaction in the Life Science sector.
  • This is Toho Holdings’ 2nd transaction in Japan.

Investment Summary

Date 2024-06-24
Target Hirosaki LI
Sector Life Science
Investor(s) Toho Holdings
Deal Type Growth Capital

Target

Hirosaki LI

Tokyo, Japan
Hirosaki LI is a bio-venture focused on developing, manufacturing, and selling regenerative medical products. The company handles excellent regenerative medical products using collagen matrices such as amniotic membrane processed sheets. It is currently engaged in the development of an autologous chondrocyte-processed product (Development code: IK-01) for the treatment of knee osteoarthritis using a three-dimensional collagen matrix. Hirosaki LI is based in Tokyo, Japan.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Toho Holdings

Hakodate, Japan

Category Company
Founded 1950
Sector Life Science
Employees621
Revenue 24.2B JPY (2025)
DESCRIPTION

Toho Holdings is focused on delivering pharmaceuticals in an accurate, secure, and safe manner. The company supports pharmaceutical distribution nationwide. While visiting medical institutions daily, it also provides support for creating a better medical care environment. Toho Holdings was founded in 1950 and is based in Hakodate, Japan.


DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 1 of 1
Type: Growth Capital M&A Deals 1 of 1
Country: Japan M&A 2 of 2
Year: 2024 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-09-21 Hakodate Nissan Jidosha K.K.

Hakodate, Japan

Hakodate Nissan Jidosha K.K. is a provides sales and repair services of automobiles.

Buy -